广州医药2024,Vol.55Issue(6) :577-584.DOI:10.3969/j.issn.1000-8535.2024.06.001

血小板药物递送系统的研究进展

Advances in platelet as drug delivery systems

贾翠萍 张媛 邓伟豪
广州医药2024,Vol.55Issue(6) :577-584.DOI:10.3969/j.issn.1000-8535.2024.06.001

血小板药物递送系统的研究进展

Advances in platelet as drug delivery systems

贾翠萍 1张媛 1邓伟豪1
扫码查看

作者信息

  • 1. 广州医科大学附属妇女儿童医疗中心(广东广州 510623)
  • 折叠

摘要

药物递送系统对于各类疾病意义非凡,但传统药物载体面临细胞毒性强、组织相容性低、半衰期短和靶向性弱等诸多挑战.血小板及其相关衍生物作为新型药物载体具有更为显著的优势.由于血小板自身的生理特点,以及在肿瘤、心血管疾病、血栓性疾病、感染等多种疾病中发挥的病理生理作用,血小板能够弥补传统药物载体的缺陷,具有极大的临床转化意义.该文总结了血小板相关药物递送系统目前的研究进展,以期为新型药物载体研究提供参考.

Abstract

Drug delivery systems are important for various diseases,but conventional therapeutic drug have many shortcomings,such as high cytotoxicity,low histocompatibility,short half-life and weak targeting.Platelets and their derivatives have more significant advantages as novel drug carriers.Platelets play an important role in the pathophysiology of a wide range of diseases including oncology,cardiovascular diseases,thrombosis and infection.In this paper,we summarized the current research progress of platelet-related drug delivery systems to provide a reference for the research of novel drug delivery systems.

关键词

血小板/仿生纳米颗粒/血小板衍生物/药物递送系统

Key words

platelet/bionic nano carriers/platelet extracellular vesicles/drug delivery system

引用本文复制引用

基金项目

国家自然科学基金(82022003)

国家自然科学基金(81970437)

广东省基础与应用基础研究基金区域联合基金(202201020651)

出版年

2024
广州医药
广州市第一人民医院

广州医药

影响因子:0.811
ISSN:1000-8535
段落导航相关论文